Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder

NCT00633802 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Borderlone Personality Disorder

Interventions

DRUG: Risperidone

Sponsor

Tel-Aviv Sourasky Medical Center